Daniel K. Spiegelman
Director · vTv Therapeutics Inc.
Individual
- 2025
- Jun 29, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel K. Spiegelman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
- Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
- Atul Dandekar - $2.27M in MAZE purchases and sales in the last 12 months
- Catherine A. Sohn - $1.15M in MAZE purchases and sales in the last 12 months
- Amy Bachrodt - $757K in MAZE purchases and sales in the last 12 months
- Phillips Courtney - $105K in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel K. Spiegelman?
Daniel K. Spiegelman is a corporate insider, tracked as Director of vTv Therapeutics Inc. (VTVT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Daniel K. Spiegelman last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 7 filings going back to 2025.
